The aim of this clinical and exploratory Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry is to establish high quality prevalence and incidence database for Cardiovascular-Kidney-Metabolic (CKM) syndrome, its major contributors, and the extent of the respective organ damaged.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Frequency of cardiovascular diseases
Timeframe: At baseline, 6, 12 months and annually up to 10 years
Frequency of kidney diseases
Timeframe: At baseline, 6, 12 months and annually up to 10 years
Frequency of liver diseases
Timeframe: At baseline, 6, 12 months and annually up to 10 years
Frequency of metabolic diseases
Timeframe: At baseline, 6, 12 months and annually up to 10 years
Frequency of microalbuminuria
Timeframe: At baseline, 6, 12 months and annually up to 5 years
Frequency of increased HbA1c
Timeframe: At baseline, 6, 12 months and annually up to 5 years
Assessment of Fib4-score
Timeframe: At baseline, 6, 12 months and annually up to 5 years
Signs of hypertensive heart disease
Timeframe: At baseline, 6, 12 months and annually up to 10 years
Signs of steatosis hepatis
Timeframe: At baseline, 6, 12 months and annually up to 5 years
Structured, registry specific questionnaire
Timeframe: At baseline and annually up to 10 years
EQ-5D-5L
Timeframe: At baseline and annually up to 10 years